Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Jiménez-Nacher

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
AIDS Reviews|August 12, 2005
Pharmacogenetics in HIV therapySonia Rodríguez-Nóvoa, Pablo Barreiro, Inmaculada Jiménez-Nacher, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfectionDaniel González-Requena, Marina Núñez, Inmaculada Jiménez-Nacher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjectsSonia Rodriguez-Novoa, Pablo Barreiro, Ana Rendón, et al.
HIV Clinical Trials|October 11, 2005
Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activityMatilde Sánchez-Conde, Carmen de Mendoza, Inmaculada Jiménez-Nacher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1Sonia Rodríguez Nóvoa, Pablo Barreiro, Ana Rendón, et al.
AIDS Research and Human Retroviruses|August 7, 2007
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patientsCarmen de Mendoza, Carolina Garrido, Angelica Corral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2008
Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovirCarmen de Mendoza, Inmaculada Jiménez-Nacher, Carolina Garrido, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI studyMatilde Sánchez-Conde, Rosario Palacios, José Sanz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
AIDS Reviews|August 12, 2005
Pharmacogenetics in HIV therapySonia Rodríguez-Nóvoa, Pablo Barreiro, Inmaculada Jiménez-Nacher, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfectionDaniel González-Requena, Marina Núñez, Inmaculada Jiménez-Nacher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjectsSonia Rodriguez-Novoa, Pablo Barreiro, Ana Rendón, et al.
HIV Clinical Trials|October 11, 2005
Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activityMatilde Sánchez-Conde, Carmen de Mendoza, Inmaculada Jiménez-Nacher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1Sonia Rodríguez Nóvoa, Pablo Barreiro, Ana Rendón, et al.
AIDS Research and Human Retroviruses|August 7, 2007
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patientsCarmen de Mendoza, Carolina Garrido, Angelica Corral, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2008
Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovirCarmen de Mendoza, Inmaculada Jiménez-Nacher, Carolina Garrido, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI studyMatilde Sánchez-Conde, Rosario Palacios, José Sanz, et al.
Pageof 1